医学
糖尿病
立场声明
血糖
语句(逻辑)
2型糖尿病
内科学
内分泌学
重症监护医学
家庭医学
法学
政治学
作者
Michael Bergman,Melania Manco,İlhan Satman,Juliana C.N. Chan,María Inês Schmidt,Giorgio Sesti,Teresa Vanessa Fiorentino,Ralph A. DeFronzo,Ram Jagannathan,Thyparambil Aravindakshan Pramodkumar,Rafael Gabriel,Viswanathan Mohan,Martin Buysschaert,Abdullah Bennakhi,André Pascal Kengne,Brenda Dorcely,Peter M. Nilsson,Jaakko Tuomilehto,Tadej Battelino,Akhtar Hussain,Antonio Ceriello,Jaakko Tuomilehto
标识
DOI:10.1016/j.diabres.2024.111589
摘要
Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D can be prevented by lifestyle modification and/or medications, in people with IGT diagnosed by 2-h plasma glucose (PG) during a 75-gram oral glucose tolerance test (OGTT). Over the last 40 years, a wealth of epidemiological data has confirmed the superior value of 1-h plasma glucose (PG) over fasting PG (FPG), glycated haemoglobin (HbA
科研通智能强力驱动
Strongly Powered by AbleSci AI